Aurora Cannabis Inc. logo

Aurora Cannabis Inc. (ACB)

Market Closed
1 Sep, 20:00
NASDAQ (CM) NASDAQ (CM)
$
4. 05
0
0%
$
250.87M Market Cap
- P/E Ratio
- Div Yield
867,977 Volume
-0.1 Eps
$ 4.05
Previous Close
Add Transaction
Day Range
4 4.09
Year Range
2.56 6.67
Want to track ACB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ACB closed today higher at $4.05, an increase of 0% from yesterday's close, completing a monthly increase of 45.1613% or $1.26. Over the past 12 months, ACB stock lost -6.0325%.
ACB is not paying dividends to its shareholders.
The last earnings report, released on Feb 04, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.4336%, based on the last three reports.
Aurora Cannabis Inc. has completed 2 stock splits, with the recent split occurring on Feb 20, 2024.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

ACB Chart

People also search for

Cardiol Therapeutics Inc.
$ 2.15
+8.8608%
Hudson Technologies Inc.
$ 5.14
-3.7453%
Organogenesis Holdings Inc.
$ 1.63
-5.2326%
TSS, Inc.
$ 7.86
-0.1271%
Journey Medical Corp
$ 7.57
+2.1592%
Should You Buy ACB Stock Amid Curaleaf's Hostile Takeover Attempt?

Should You Buy ACB Stock Amid Curaleaf's Hostile Takeover Attempt?

Aurora Cannabis faces a potential Curaleaf takeover at a 45% premium, but investors must weigh the offer against ACB's standalone prospects.

Zacks | 2 weeks ago
Aurora Cannabis Inc. (ACB) Q1 Earnings and Revenues Beat Estimates

Aurora Cannabis Inc. (ACB) Q1 Earnings and Revenues Beat Estimates

Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.13 per share. This compares to a loss of $0.19 per share a year ago.

Zacks | 3 weeks ago
ACB Stock Down 28% in Three Months: Time to Buy the Dip or Cash Out?

ACB Stock Down 28% in Three Months: Time to Buy the Dip or Cash Out?

Aurora Cannabis' shares plunge 28% in three months as a cautious fiscal 2027 outlook overshadows record medical cannabis growth and global expansion.

Zacks | 1 month ago

Aurora Cannabis Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
BZ
Brandon Zatopek Commonwealth Equity Services LLC
23,915 $66,719 $71,505.85 $4,786.85 7.17%
JD
Jim Dushek HARBOUR INVESTMENTS Inc.
3,277 $11,337.35 $11,420.34 $82.99 0.73%
NA
Nizar Araji National Bank Of Canada /FI/
270,463.6 $927,032.57 $803,276.89 -$123,755.68 -13.35%
BR
Bill Reuther SILVER OAK SECURITIES Inc.ORPORATED
37,223 $174,986.13 $111,296.77 -$63,689.36 -36.4%
Point72 Asset Management LP
Point72 Asset Management LP Point72 Asset Management LP
10,665 $30,104 $39,300.52 $9,196.52 30.55%

Aurora Cannabis Inc. (ACB) FAQ

What is the stock price today?

The current price is $4.05.

On which exchange is it traded?

Aurora Cannabis Inc. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is ACB.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 250.87M.

Has Aurora Cannabis Inc. ever had a stock split?

Aurora Cannabis Inc. had 2 splits and the recent split was on Feb 20, 2024.

Aurora Cannabis Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Miguel Martin CEO
NASDAQ (CM) Exchange
05156X850 CUSIP
CA Country
1,028 Employees
11 May 2020 Last Dividend
20 Feb 2024 Last Split
11 Jul 2014 IPO Date

Overview

Aurora Cannabis Inc. is a leader in the global cannabis industry, engaging in the production, distribution, and sale of cannabis and its derivatives across Canada and international markets. The company operates through three core segments: Canadian Cannabis, European Cannabis, and Plant Propagation. Its strategies include not only addressing the medical and consumer cannabis markets in Canada but also distributing wholesale medical cannabis throughout the European Union, various international regions such as Australia, the Caribbean, South America, and Israel, and providing supply for propagated vegetables and ornamental plants in North America. Furthermore, Aurora Cannabis extends its presence into the distribution and sale of hemp-derived CBD products. Based in Edmonton, Canada, the company has carved out a competitive position in the global landscape by focusing on diverse product offerings and comprehensive patient counseling and outreach services.

Products and Services

  • Dried Cannabis, Cannabis Oils, and Capsules

    Aurora Cannabis produces a range of consumables including dried cannabis, cannabis oils, and capsules. These products are designed for multiple modes of consumption such as smoking, vaporizing, or ingestion in oil, capsule, or edible form. Each method offers a distinctive experience tailored to consumer and medical patient preferences.

  • Edible Cannabis, Extracts, and Soft Gels

    The company's portfolio includes edible cannabis products, extracts, and soft gels. These products provide alternatives for those preferring not to inhale their cannabis, offering a variety of potencies and formulas to suit a diverse client base with specific needs.

  • Recreational Cannabis Products

    Aurora's recreational cannabis products span categories such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products. These offerings fall under brands like Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, enabling Aurora to cater to a broad range of consumer tastes and preferences.

  • Medical Cannabis Brands

    With a focus on patient needs, Aurora offers medical cannabis products under brands such as MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. These products are developed to support patients with specific therapeutic needs, ensuring high quality and efficacy.

  • Hemp-derived CBD Products

    Aurora distributes and sells a variety of hemp-derived CBD products, including brands like Reliva and KG7. These products cater to the growing demand for non-psychoactive cannabinoid products, offering benefits without the high associated with THC.

  • Patient Counseling and Outreach Services

    Beyond physical products, Aurora Cannabis extends its services to include patient counseling and outreach. This service demonstrates Aurora's commitment to the well-being of its customers, providing valuable information, support, and guidance on the use of cannabis for medical purposes.

Contact Information

Address: 90B Street SW
Phone: 16043625207